In this interview conducted at Pittcon 2024 in San Diego, we spoke to this year’s Keynote Speaker Professor Omowunmi (Wunmi) Sadik about how sustainable nanomaterials
The study findings suggest that self-management strategies for hypertension may effectively reduce blood pressure levels over 24 months without increasing healthcare resource utilization or adverse
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their
Researchers investigate whether experiencing discrimination is associated with accelerated biological processes of aging.
Top of the morning to you, and a fine one it is, despite the gray skies hovering over the Pharmalot campus again. Our spirits remain
As pediatricians who take care of children in the inpatient, emergency, and primary care settings, we are alarmed by the recent trend of families having
A plan to use new genetic techniques to treat non-genetic forms of ALS failed in an early study, Ionis and Biogen announced Thursday. The companies
The efficiency of the HPV vaccination program in reducing the prevalence of cervical cancers.
The need-to-know this morning Biogen and Ionis Pharmaceuticals are ending their development of an experimental drug for ALS based on results of a Phase 1/2 trial. Johnson & Johnson said it
Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global